A Phase3 Study to Evaluate the Efficacy and Safety of MEDI3250 in Healthy Japanese Children Age 7 Years Through 18 Years
Clinical trial NCT02269475 · COMPLETED
Trial details
- NCT number
- NCT02269475
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2015-04-01
- Enrollment
- 1369
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.